Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Can J Neurol Sci ; 51(1): 117-121, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36710572

RESUMO

Dr. Sharpe was a leading eye movement researcher who had also been the editor of this journal. We wish to mark the 10th anniversary of his death by providing a sense of what he had achieved through some examples of his research.


Assuntos
Neurologia , Oftalmologia , Humanos , Masculino , Oftalmologia/história
2.
Fertil Steril ; 93(4): 1169-72, 2010 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-19135656

RESUMO

OBJECTIVE: To evaluate the impact of clomiphene citrate on vision. DESIGN: Observational study. SETTING: Patients were referred to the University of Ottawa Eye Institute ophthalmology clinic from the Department of Obstetrics and Gynaecology of the Ottawa Hospital-General Campus. PATIENT(S): Eight adult females taking clomiphene citrate and experiencing visual disturbances. INTERVENTION(S): Patients received a comprehensive visual evaluation twice: once during a washout period, and once during an active clomiphene citrate treatment. MAIN OUTCOME MEASURE(S): Ophthalmologic examination, color vision, visual acuity, contrast sensitivity, visual fields using standard automated perimetry, and foveal flicker sensitivity at high (32 Hz) and low (8 Hz) temporal frequencies. RESULT(S): We found no differences between the washout and clomiphene citrate conditions for color vision, visual acuity, contrast sensitivity, and visual fields. The only statistically significant difference was found for foveal flicker sensitivity at 32 Hz in the right eye, with a similar trend in the left eye and at 8 Hz in both eyes. CONCLUSION(S): The effect of clomiphene citrate on vision was minimal, and the visual disturbances were reversible in all patients. A bilateral reduction in flicker sensitivity was the only observed visual disturbance. Women who experience visual symptoms associated with clomiphene citrate should be monitored, but therapy can usually be maintained.


Assuntos
Clomifeno/análogos & derivados , Clomifeno/efeitos adversos , Percepção de Cores/efeitos dos fármacos , Fármacos para a Fertilidade Feminina/efeitos adversos , Fusão Flicker/efeitos dos fármacos , Acuidade Visual/efeitos dos fármacos , Campos Visuais/efeitos dos fármacos , Adulto , Clomifeno/farmacologia , Percepção de Cores/fisiologia , Sensibilidades de Contraste/efeitos dos fármacos , Sensibilidades de Contraste/fisiologia , Feminino , Fármacos para a Fertilidade Feminina/farmacologia , Fusão Flicker/fisiologia , Humanos , Acuidade Visual/fisiologia , Campos Visuais/fisiologia
3.
Ann Neurol ; 59(6): 963-9, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16718705

RESUMO

OBJECTIVE: To determine to what degree changes in retinal nerve fiber layer (RNFL) thickness after optic neuritis (ON) correlate with either visual recovery or impairment. METHODS: ON can cause visible defects within the RNFL, which can be quantified using optical coherence tomography (OCT). It may be possible to predict visual recovery by measuring RNFL loss after ON. Fifty-four patients underwent repeated evaluations with optical coherence tomography and standardized ophthalmic testing after ON. Regression analyses were used to determine the relationship between RNFL thickness and visual function. RESULTS: Thinning of the RNFL was seen in the majority of patients (74%), and it tended to occur within 3 to 6 months of ON. The average RNFL value was thinner (p<0.0001) in the affected (78 microm) compared with the unaffected eye (100 microm). Patients with incomplete visual recovery demonstrated greater RNFL loss after ON. Regression analyses demonstrated a threshold of RNFL thickness (75 microm), below which RNFL measurements predicted persistent visual dysfunction. INTERPRETATION: Determination of RNFL thickness may predict visual recovery after ON, and lower RNFL values correlate with impaired visual function. Optical coherence tomography may have a potential role as a surrogate marker for axonal integrity within the optic nerve among patients with ON.


Assuntos
Axônios/patologia , Degeneração Neural/diagnóstico , Neurite Óptica/patologia , Retina/patologia , Tomografia de Coerência Óptica , Adolescente , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Degeneração Neural/etiologia , Neurite Óptica/complicações , Prognóstico , Estudos Prospectivos , Recuperação de Função Fisiológica , Transtornos da Visão/diagnóstico , Transtornos da Visão/etiologia , Testes Visuais , Campos Visuais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...